1 |
Vallet-Pichard A, Mallet V, Nalpas B, et al (2007). FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatol, 46, 32-6.
DOI
|
2 |
Bate N, Gingras AR, Bachir A, et al (2012). Talin contains a C-terminal calpain2 cleavage site important in focal adhesion dynamics. PLoS One, 7, 34461.
DOI
|
3 |
Bostanci O, Kemik O, Kemik A, et al (2014). A novel screening test for colon cancer: Talin-1. Eur Rev Med Pharmacol Sci, 18, 2533-7.
|
4 |
Bota S, Sirli R, Sporea I, et al (2011). A new scoring system for prediction of fibrosis in chronic hepatitis C. Hepat Mon, 11, 548-55.
|
5 |
Bravi F, Bosetti C, Tavani A, et al (2013). Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol, 11, 1413-21.
DOI
|
6 |
Bruix J, Gores GJ, Mazzaferro V (2014). Hepatocellular carcinoma: clinical frontiers and perspectives. Gut, 63, 844-55.
DOI
|
7 |
Byam J, Renz J, Millis JM (2013). Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr, 2, 22-30.
|
8 |
Chan AW, Kumada T, Toyoda H, et al (2016). Integration of albumin-bilirubin (ALBI) score into Barcelona clinic liver cancer (BCLC) system for hepatocellular carcinoma. J Gastroenterol Hepatol.
|
9 |
Youns MM, Abdel Wahab AH, Hassan ZA, et al (2013). Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Asian Pac J Cancer Prev, 14, 3819-23.
DOI
|
10 |
Waller LP, Deshpande V, Pyrsopoulos N (2015). Hepatocellular carcinoma: A comprehensive review. World J Hepatol, 7, 2648-63.
DOI
|
11 |
Zhang JL, Qian YB, Zhu LX, et al (2011). Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas. Asian Pac J Cancer Prev, 12, 3265-9.
|
12 |
Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55.
DOI
|
13 |
Chung HA, Kim JH, Hwang Y, et al (2016). Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation. Saudi J Gastroenterol, 22, 57-63.
DOI
|
14 |
Cross TJ, Rizzi P, Berry PA, et al (2009). King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol, 21, 730-8.
DOI
|
15 |
Desiniotis A, Kyprianou N (2011). Significance of talin in cancer progression and metastasis. Int Rev Cell Mol Biol, 289, 117-47.
|
16 |
European Association for the Study of the L, European Organisation for R, Treatment of C EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol, 56, 908-43.
|
17 |
Fang KP, Zhang JL, Ren YH, et al (2014). Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells. Asian Pac J Cancer Prev, 15, 2655-61.
DOI
|
18 |
Hann HW, Wan S, Lai Y, et al (2015). Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol, 30, 131-8.
DOI
|
19 |
Hiraoka A, Kumada T, Michitaka K, et al (2015). Usefulness of albumin-bilirubin (ALBI) grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J Gastroenterol Hepatol.
|
20 |
Islam S, Antonsson L, Westin J, et al (2005). Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol, 40, 867-72.
DOI
|
21 |
Ito T, Kumada T, Toyoda H, et al (2015a). FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function. J Cancer Res Clin Oncol, 141, 1311-9.
DOI
|
22 |
Lok AS, Ghany MG, Goodman ZD, et al (2005). Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatol, 42, 282-92.
|
23 |
Ito T, Kumada T, Toyoda H, et al (2015b). Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels. J Viral Hepat, 22, 777-83.
DOI
|
24 |
Johnson PJ, Berhane S, Kagebayashi C, et al (2015). Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol, 33, 550-8.
DOI
|
25 |
Kim TK, Lee E, Jang HJ (2015). Imaging findings of mimickers of hepatocellular carcinoma. Clin Mol Hepatol, 21, 326-43.
DOI
|
26 |
Kirstein MM, Vogel A (2014). The pathogenesis of hepatocellular carcinoma. Dig Dis, 32, 545-53.
DOI
|
27 |
Lai MT, Hua CH, Tsai MH, et al (2011). Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J Pathol, 224, 367-76.
DOI
|
28 |
Ogasawara S, Chiba T, Ooka Y, et al (2015). Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs.
|
29 |
Ohta T, Sakaguchi K, Fujiwara A, et al (2006). Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Acta Med Okayama, 60, 77-84.
|
30 |
Omran MM, Farid K, Emran TM, et al (2011). Fibro- score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol, 12, 74-9.
DOI
|
31 |
Sakamoto S, McCann RO, Dhir R, et al (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res, 70, 1885-95.
DOI
|
32 |
Pang Q, Bi JB, Xu XS, et al (2015). King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 27, 1337-46.
DOI
|
33 |
Park LS, Tate JP, Justice AC, et al (2011). FIB-4 index is associated with hepatocellular carcinoma risk in HIVinfected patients. Cancer Epidemiol Biomarkers Prev, 20, 2512-7.
DOI
|
34 |
Pinato DJ, Karamanakos G, Ishizuka M, et al (2015). The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application. Liver Int, 35, 2458-65.
DOI
|
35 |
Schuppan D, Afdhal NH (2008). Liver cirrhosis. Lancet, 371, 838-51.
DOI
|
36 |
Shaheen AA, Myers RP (2007). Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatol, 46, 912-21.
DOI
|
37 |
Shen SL, Fu SJ, Chen B, et al (2014). Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection. Ann Surg Oncol, 21, 3802-9.
DOI
|
38 |
Song PP, Xia JF, Inagaki Y, et al (2016). Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol, 22, 262-74.
DOI
|
39 |
Suh B, Park S, Shin DW, et al (2015). High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatol, 61, 1261-8.
DOI
|